• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VERYAN MEDICAL LTD BIOMIMICS 3D VASCULAR STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VERYAN MEDICAL LTD BIOMIMICS 3D VASCULAR STENT SYSTEM Back to Search Results
Catalog Number 142122-02
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Restenosis (4576); Swelling/ Edema (4577)
Event Date 06/29/2023
Event Type  Injury  
Event Description
This is related to mdr number 3011632150-2023-00146.The patient was treated as part of the mimics 3d usa post-market observational study.On the (b)(6) 2021, the patient was implanted with two biomimics 3d (bm3d) stents.A 5.0 x 125 mm bm3d stent and a 6.0 x 60 mm bm3d (the subject of this report) stent.They were used to treat a denovo lesion in the superficial femoral artery (sfa) middle third to sfa distal third artery in the left leg.A contralateral approach was used and the lesion was prepared using pre-dilation with percutaneous transluminal angioplasty (pta) balloon and atherectomy.The treated segment was post-dilated with pta.On the (b)(6) 2023, an event of restenosis of treated segment (target lesion) was identified.It was site reported as possibly related to the device and not related to the procedure.It was target lesion related.The patient attended the office on (b)(6) 2023 complaining of significant swelling and pain in her left leg (target leg).She had a left leg extremity (lle) angiogram on (b)(6) 2023 which showed that the entire sfa that had previously been stented had significant stenosis throughout the entire region.The proximal popliteal segment also showed some evidence of the disease in the native segment but beyond this, the popliteal artery appeared otherwise normal.The common femoral artery also showed moderate stenosis and the distal common femoral artery, the entire stented region of the sfa and the proximal popliteal artery were treated with pta / standard balloon angioplasty.Completion arteriography showed an excellent result with brisk flow through all the treated sections.It was reported as a target lesion/vessel revascularisation (tlr/tvr).The patient outcome was reported as resolved/recovered and the devices remain implanted.
 
Manufacturer Narrative
This is related to mdr number 3011632150-2023-00146.There was no reported device malfunction and the device was not returned for analysis.A review has been performed of the manufacturing certificate of conformance associated with this lot.There were no non-conformances or deviations which could be associated with this event.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effects of restenosis leading to intervention, leg/pain/claudication, swelling/oedema (as ischemia) are listed in the biomimics 3d instructions for use and are known patient effects of peripheral stenting procedures.There is no indication of a product quality issue with respect to the design, manufacture or labelling of the device.If further information regarding this event becomes available, a follow-up report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOMIMICS 3D VASCULAR STENT SYSTEM
Type of Device
BIOMIMICS 3D VASCULAR STENT SYSTEM
Manufacturer (Section D)
VERYAN MEDICAL LTD
block 5
parkmore east business park
galway, H91 V 0TX
EI  H91 V0TX
Manufacturer Contact
alan mcdonagh
block 5
parkmore east business park
galway, H91 V-0TX
EI   H91 V0TX
MDR Report Key18496827
MDR Text Key332694957
Report Number3011632150-2023-00147
Device Sequence Number1
Product Code NIP
UDI-Device Identifier05391526850398
UDI-Public(01)05391526850398(17)221007(11)210308(10)0000076760
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 01/11/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/11/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/07/2022
Device Catalogue Number142122-02
Device Lot Number0000076760
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/14/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/08/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ASPIRIN.; CILOSTAZOL (PLETAL).; CLOPIDOGREL (PLAVIX).
Patient Outcome(s) Required Intervention;
Patient Age80 YR
Patient SexFemale
Patient Weight61 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-